348 related articles for article (PubMed ID: 17460445)
21. Ebastine in allergic rhinitis and chronic idiopathic urticaria.
Sastre J
Allergy; 2008 Dec; 63 Suppl 89():1-20. PubMed ID: 19032340
[TBL] [Abstract][Full Text] [Related]
22. The effects of the nasal antihistamines olopatadine and azelastine in nasal allergen provocation.
Pipkorn P; Costantini C; Reynolds C; Wall M; Drake M; Sanico A; Proud D; Togias A
Ann Allergy Asthma Immunol; 2008 Jul; 101(1):82-9. PubMed ID: 18681089
[TBL] [Abstract][Full Text] [Related]
23. Eosinophil recruiting chemokines are down-regulated in peripheral blood mononuclear cells of allergic patients treated with deflazacort or desloratadine.
Di Sciascio MB; Vianale G; Verna N; Petrarca C; Perrone A; Toniato E; Muraro R; Conti P; Di Gioacchino M
Int J Immunopathol Pharmacol; 2007; 20(4):745-51. PubMed ID: 18179747
[TBL] [Abstract][Full Text] [Related]
24. [In seasonal and perennial rhinitis. Superiority to standard H1 blockers].
MMW Fortschr Med; 2003 May; 145(22):51. PubMed ID: 12866281
[No Abstract] [Full Text] [Related]
25. Preseasonal prophylactic treatment with antihistamines suppresses IL-5 but not IL-33 mRNA expression in the nasal mucosa of patients with seasonal allergic rhinitis caused by Japanese cedar pollen.
Kitamura Y; Mizuguchi H; Ogishi H; Kuroda W; Hattori M; Fukui H; Takeda N
Acta Otolaryngol; 2012 Apr; 132(4):434-8. PubMed ID: 22216765
[TBL] [Abstract][Full Text] [Related]
26. Nasal allergic response mediated by histamine H3 receptors in murine allergic rhinitis.
Nakaya M; Fukushima Y; Takeuchi N; Kaga K
Laryngoscope; 2005 Oct; 115(10):1778-84. PubMed ID: 16222194
[TBL] [Abstract][Full Text] [Related]
27. Pharmacological, pharmacokinetic and clinical properties of olopatadine hydrochloride, a new antiallergic drug.
Ohmori K; Hayashi K; Kaise T; Ohshima E; Kobayashi S; Yamazaki T; Mukouyama A
Jpn J Pharmacol; 2002 Apr; 88(4):379-97. PubMed ID: 12046981
[TBL] [Abstract][Full Text] [Related]
28. Olopatadine inhibits anti-immunoglobulin E-stimulated conjunctival mast cell upregulation of ICAM-1 expression on conjunctival epithelial cells.
Cook EB; Stahl JL; Barney NP; Graziano FM
Ann Allergy Asthma Immunol; 2001 Nov; 87(5):424-9. PubMed ID: 11730187
[TBL] [Abstract][Full Text] [Related]
29. Diesel exhaust particulates upregulate histamine receptor mRNA and increase histamine-induced IL-8 and GM-CSF production in nasal epithelial cells and endothelial cells.
Terada N; Hamano N; Maesako KI; Hiruma K; Hohki G; Suzuki K; Ishikawa K; Konno A
Clin Exp Allergy; 1999 Jan; 29(1):52-9. PubMed ID: 10051702
[TBL] [Abstract][Full Text] [Related]
30. Overview of allergic mechanisms. Ebastine has more than an antihistamine effect.
Campbell A; Michel FB; Bremard-Oury C; Crampette L; Bousquet J
Drugs; 1996; 52 Suppl 1():15-9. PubMed ID: 8983912
[TBL] [Abstract][Full Text] [Related]
31. Comparison of efficacy and safety of cetirizine and ebastine in patients with perennial allergic rhinitis.
Murris-Espin M; Melac M; Charpentier JC; Didier A
Ann Allergy Asthma Immunol; 1998 May; 80(5):399-403. PubMed ID: 9609610
[TBL] [Abstract][Full Text] [Related]
32. Olopatadine nasal spray for the treatment of seasonal allergic rhinitis in patients aged 6 years and older.
Roland PS; Ryan MW; Wall GM
Expert Opin Pharmacother; 2010 Jun; 11(9):1559-67. PubMed ID: 20482305
[TBL] [Abstract][Full Text] [Related]
33. The antagonism of histamine H1 and H4 receptors ameliorates chronic allergic dermatitis via anti-pruritic and anti-inflammatory effects in NC/Nga mice.
Ohsawa Y; Hirasawa N
Allergy; 2012 Aug; 67(8):1014-22. PubMed ID: 22686688
[TBL] [Abstract][Full Text] [Related]
34. Antiallergic anti-inflammatory effects of H1-antihistamines in humans.
Assanasen P; Naclerio RM
Clin Allergy Immunol; 2002; 17():101-39. PubMed ID: 12113215
[TBL] [Abstract][Full Text] [Related]
35. New H1/H3 antagonists for treating allergic rhinitis: WO2010094643.
Norman P
Expert Opin Ther Pat; 2011 Mar; 21(3):425-9. PubMed ID: 21342057
[TBL] [Abstract][Full Text] [Related]
36. Effect of histamine on the permeability of the nasal mucosa in vivo.
Yang TQ; Takeuchi K; Hayashi S; Majima Y
Acta Otolaryngol; 2003 Apr; 123(3):401-5. PubMed ID: 12737298
[TBL] [Abstract][Full Text] [Related]
37. Eotaxin mRNA and protein expression in chronic sinusitis and allergen-induced nasal responses in seasonal allergic rhinitis.
Minshall EM; Cameron L; Lavigne F; Leung DY; Hamilos D; Garcia-Zepada EA; Rothenberg M; Luster AD; Hamid Q
Am J Respir Cell Mol Biol; 1997 Dec; 17(6):683-90. PubMed ID: 9409555
[TBL] [Abstract][Full Text] [Related]
38. Involvement of thromboxane A2 and histamine in experimental allergic rhinitis of guinea pigs.
Yamasaki M; Matsumoto T; Fukuda S; Nakayama T; Nagaya H; Ashida Y
J Pharmacol Exp Ther; 1997 Mar; 280(3):1471-9. PubMed ID: 9067337
[TBL] [Abstract][Full Text] [Related]
39. Inhibitory effect of olopatadine on antigen-induced eosinophil infiltration and the LFA-1 and Mac-1 expression in eosinophils.
Fukuishi N; Matsuhisa M; Shimono T; Murata N; Iwanaga M; Sagara H; Matsui N; Akagi M
Jpn J Pharmacol; 2002 Apr; 88(4):463-6. PubMed ID: 12046991
[TBL] [Abstract][Full Text] [Related]
40. Characterization of the ocular antiallergic and antihistaminic effects of olopatadine (AL-4943A), a novel drug for treating ocular allergic diseases.
Sharif NA; Xu SX; Miller ST; Gamache DA; Yanni JM
J Pharmacol Exp Ther; 1996 Sep; 278(3):1252-61. PubMed ID: 8819509
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
